Skip to main content
. 2020 Dec 21;10:570187. doi: 10.3389/fonc.2020.570187

Table 1.

Patient characteristics.

N M/F Age Type FISH:S/H N.Previous lines Dara-therapy N.Dara previous infusions IRR1 dose N.Rapid infusions IRR in Rapid infusions Disease status before Dara Bestresponse PD:Y/N FUO/infection A/D
1 M 68 IgA κ S 3 DVd 16 No 4 None RR PR Y Yes Dead
2 M 84 IgG κ S 6 DRd 3 No 28 None RR PR N Yes Alive
3 M 57 IgG κ ND 4 DVd 5 No 18 None RR PR N Yes Alive
4 M 60 BJ.κ H 6 DRd 3 No 24 None RR PR Y Yes Dead
5 M 53 IgG κ H 2 DPd 2 Yes 12 None RR SD Y Yes Dead
6 M 71 IgG κ N 1 DRd 2 No 21 None RR CR N No Alive
7 M 58 BJ.λ S 1 DRd 2 Yes 19 None RR PR N Yes Alive
8 F 62 IgG λ N 6 Dara alone 13 No 1 None RR PR Y Yes Dead
9 M 57 IgG λ N 3 DRd 5 Yes 7 None RR SD Y No Dead
10 M 65 IgG λ N 1 DRd 2 Yes 4 None RR VGPR N Yes Alive
11 M 63 BJ λ N 1 Dara alone 2 No 19 None RR VGPR N Yes Alive
12 M 63 IgG λ ND 1 Dara alone 12 No 18 None RR PR N No Alive
13 M 49 IgG/k H 6 Dara Alone 13 No 4 None RR PR Y No Dead
14 F 55 IgG/k H 2 DVd 2 No 11 None RR PR N No Alive
15 F 63 IgG/k S 6 DRd 2 No 9 None RR VGPR N No Alive
16 M 64 BJ/λ S 2 DRd 2 No 7 None RR VGPR N No Alive
17 M 45 IgG/k S 1 DRd 2 No 1 None RR NA N No Alive
18 M 61 IgG/k S 4 DVd 2 No 1 None RR NA N No Alive
19 F 63 BJ/λ S 1 DRd 2 Yes 1 None RR NA N No Alive
20 F 51 IgG κ S 1 DART4MM 2 No 21 None CR-MRD pos CR N No Alive
21 F 63 IgG κ S 1 DART4MM 2 No 14 None CR-MRD pos CR N No Alive
22 M 71 IgA λ S 1 DART4MM 2 No 14 None VGPR sCR-MRD neg N No Alive
23 M 62 IgG k S 1 DART4MM 2 No 16 None CR-MRD pos CR N No Alive
24 F 65 IgG k S 1 DART4MM 2 No 16 None VGPR VGPR N No Alive
25 F 72 IgG λ H 1 DART4MM 3 Yes 26 None VGPR VGPR Y No Alive
26 F 78 IgG κ N 1 DART4MM 2 Yes 30 None VGPR CR N No Alive
27 M 71 IgG κ S 1 DART4MM 2 No 14 None VGPR sCR-MRD neg N No Alive
28 M 66 IgG λ ND 1 DART4MM 2 No 14 None VGPR CR-MRD neg N No Alive
29 F 65 IgG λ S 1 DART4MM 2 Yes 14 None CR-MRD pos CR-MRD neg N No Alive
30 M 55 BJ λ ND 1 DART4MM 2 No 14 None CR-MRD pos CR-MRD neg N No Alive
31 M 58 IgG κ S 1 DART4MM 2 Yes 14 None VGPR CR-MRD neg N No Alive
32 M 48 IgG λ S 1 DART4MM 2 No 14 None CR-MRD pos CR-MRD neg N No Alive
33 M 70 IgG/k S 1 DART4MM 2 No 18 None VGPR VGPR N No Alive
34 F 66 IgG/k S 1 DART4MM 2 No 12 None VGPR CR N No Alive
35 M 65 IgG/k S 1 DART4MM 2 Yes 15 None VGPR VGPR N No Alive
36 M 66 IgG k S 1 DART4MM 2 No 5 None VGPR NA N No Alive
37 M 62 IgG/k S 1 DART4MM 2 Yes 2 None CR-MRD pos NA N No Alive
38 M 52 IgG/k S 1 DART4MM 2 Yes 1 None VGPR NA N No Alive
39 F 59 IgG/k S 1 DART4MM 2 Yes 1 None VGPR NA N No Alive

FISH : ND, not done; H = high risk (t 4;14-t14;16-del 17p); S, standard risk (all other anomalies); N, normal; DVd, dara, velcade, dexamethasone; DRd, Dara, Revlimid, dexamethasone; DPd, Dara, Pomalidomide, dexamethasone; NA, not applicable (too early for assessment); IRR, infusion-related reaction; FUO, fever of unknown origin.

N Rapid infusions and IRRR in Rapid infusions columns are evidenced in bold.